Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 313 for “"Plasma cell"”.
-
Molecular physiology of plasma cell differentiation
Plasma cells are central to an effective immune response, being the sole producers of the antibodies, yet they can cause severe disease in autoimmunity and multiple myeloma. Therefore their differentiation and survival must be tightly regulated. In this work I investigated some of the mechanisms …
-
Diagnostic delay in plasma cell dyscrasias
Background: Multiple myeloma is associated with significant diagnostic delay, and early mortality, particularly after emergency presentation. Given the varied symptoms of myeloma, symptom-based strategies to improve diagnosis may be ineffective - alternative strategies are needed. Methods: 1) …
-
Clinical development of daratumumab in plasma cell dyscrasias
Το πολλαπλούν μυέλωμα(ΠΜ) είναι μια αιματολογική κακοήθεια που χαρακτηρίζεται από τον ανεξέλεγκτο πολλαπλασιασμό των πλασματοκυττάρων και την υπερβολική παραγωγή ενός ειδικού τύπου ανοσοσφαιρίνης. Επί του παρόντος, το ΠΜ είναι μια ανίατη ασθένεια και υπάρχει επιτακτική ανάγκη για νέες θεραπευτικές …
-
Clinical development of Ixazomib in plasma cell dyscrasias
Εισαγωγή: Οι αναστολείς πρωτεασώματος (PIs) αποτελούν αναπόσπαστο μέρος της θεραπείας για πολλαπλό μυέλωμα (ΜΜ) κατά την τελευταία δεκαετία. Πολλά νεότερα PI αξιολογούνται σε προ-κλινικό και κλινικό περιβάλλον, με στόχο τη βελτίωση του προφίλ ασφάλειας, αποτελεσματικότητας και αντοχής αυτής της …
-
Clinical development of carfilzomib in plasma cell dyscrasias
Οι αναστολείς πρωτεασώματος αποτελούν βασικά φάρμακα νέας γενιάς για τη θεραπεία του Πολλαπλού Μυελώματος. Η καρφιλζομίμπη, ο δεύτερος κατά σειρά αναστολέας πρωτεασώματος αναπτύχθηκε το 2008 και ονομάστηκε Kyprolis (PR-171). Αργότερα, η καρφιλζομίμπη συμμετείχε σε Κλινικές Δοκιμές φάσης I, II, III …
-
Three-Dimensional Plasma Cell Survival Microniche in Multiple Myeloma
… by the uncontrolled proliferation of long-lived plasma cells (PCs) in the bone marrow (BM), which constitute at least 10% of BM cellularity. Normally, long-lived plasma cells make up less than 1% of BM cells. Plasma cells become neoplastic when a clonal PC population produces a monoclonal …
-
Three-Dimensional Plasma Cell Survival Microniche in Multiple Myeloma
… by the uncontrolled proliferation of long-lived plasma cells (PCs) in the bone marrow (BM), which constitute at least 10% of BM cellularity. Normally, long-lived plasma cells make up less than 1% of BM cells. Plasma cells become neoplastic when a clonal PC population produces a monoclonal …
-
Influence of megakaryocytes and megakaryocytopoiesis on plasma cell survival
… a specific microenvironment composed of stromal cells, haematopoietic stem cells and cytokines. MKs constitute an important niche component as major sources of APRIL and IL-6. TPO is the crucial growth factor for MKs and c-mpl, its receptor. Thus, alterations in megakaryopoiesis can change …
-
Molecular modelling of MYC hyperfunction in plasma cell differentiation
… factor in the germinal centre (GC). Long-lived plasma cells (PCs) are generated mainly from a GC response and their differentiation requires MYC downregulation. MYC can also act as a potent oncogene when deregulated being involved in multiple mature B cell cancers. Tumour cells overexpressing …
-
Genetic analyses of multiple myeloma and related plasma cell dyscrasias
… is known about the karyotypic features of these plasma cell dyscrasias. One reason for this is that a large proportion of the cases are karyotypically normal, despite the fact that molecular genetic studies have revealed that virtually all MM and most MGUS harbor cytogenetic aberrations. Thus, …
-
CD28 Regulates Metabolic Fitness for Long-Lived Plasma Cell Survival
… survival of bone marrow (BM) resident long-lived plasma cells (LLPC). However, the mechanisms governing LLCP survival are not completely understood. We have previously shown that CD28, the prototypic T cell costimulatory molecule, is essential for the survival of LLPC but not SLPC through its …
-
Plasma cell differentiation in the B-cell malignancy Waldenström Macroglobulinemia
… macroglobulinemia (WM) is unique amongst B-cell malignancies in that the neoplastic cells retain the capacity to undergo plasma cell differentiation. This gives rise to a clonal neoplasm encompassing the spectrum of differentiation and as such presents a challenge to model and treat …
-
Nanomanipulator perturbation of dust crystals in a GEC rf plasma cell.
… of observable matter is composed of complex plasma. Even with its prevalence, the interactions between the plasma's constituents are not fully understood. In many cases, clouds of dust grains from and can even display organized, crystal-like, structures. Understanding the interparticle forces …
-
Adhesion and niche residency factors in plasma cell differentiation and neoplasia
… incredibly complex due to the nature of immune cell maturation and the stages that malignancies can arise. Therefore, understanding the underlying mechanisms of survival, homing and migration to the survival niche will aid diagnosis and understanding of disease metastasis. This project aims to …
-
Defining Human Plasma Cell Precursors and Differentiation Trajectories Through Multiomic Profiling
Plasma cells are the mediators of humoral immunity due to their potential for long-term secretion of antigen-specific antibodies. While certain core aspects of plasma cell biology have been well established, such as their lineage-defining transcription factors IRF4 and Blimp-1, their ultimate …
-
Monogenetic Immune Dysregulation Syndromes and their Effect on the Plasma Cell Compartment
… diseases, these interactions are altered. Plasma cells (PC) and their B cell progenitors, that play a key role in maintaining humoral and cellular memory, are impaired within these patients. We characterised different features of plasma cells in immune dysregulated individuals via flow …
-
Toward Personalized Medicine: The potential role of RNA interference in Plasma Cell Dyscrasia
… major contributor to mortality in patients with plasma cell dyscrasias (PCDs); i.e., multiple myeloma, light chain deposition disease and AL amyloidosis is the deposition as insoluble aggregates of monoclonal immunoglobulin light chain proteins (LC) in the kidneys and other organs. Currently …
Page 1 of 16